Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Karin Frank-Raue"'
Autor:
Viktoria Florentine Koehler, Pia Adam, Carmina Teresa Fuss, Linmiao Jiang, Elke Berg, Karin Frank-Raue, Friedhelm Raue, Eva Hoster, Thomas Knösel, Hans-Ulrich Schildhaus, Thomas Negele, Udo Siebolts, Kerstin Lorenz, Stephanie Allelein, Matthias Schott, Christine Spitzweg, Matthias Kroiss
Publikováno v:
Cancers, Vol 14, Iss 14, p 3405 (2022)
Background: RET (rearranged during transfection) variants are the most prevalent oncogenic events in medullary thyroid cancer (MTC). In advanced disease, multi-tyrosine kinase inhibitors (MKIs) cabozantinib and vandetanib are the approved standard tr
Externí odkaz:
https://doaj.org/article/4229dd3287e140f0950f549ca3805ab6
Autor:
Friedhelm Raue, Karin Frank-Raue
Publikováno v:
Clinics, Vol 67, Pp 69-75 (2012)
Multiple endocrine neoplasia type 2 is an autosomal-dominant hereditary cancer syndrome caused by missense gain-of-function mutations of the rearranged during transfection proto-oncogene, which encodes the receptor tyrosine kinase, on chromosome 10.
Externí odkaz:
https://doaj.org/article/b405be7fd0ad4373be083769eae60447
Autor:
Saskia Letz, Christine Haag, Egbert Schulze, Karin Frank-Raue, Friedhelm Raue, Benjamin Hofner, Bernhard Mayr, Christof Schöfl
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115178 (2014)
Activating calcium sensing receptor (CaSR) mutations cause autosomal dominant hypocalcemia (ADH) characterized by low serum calcium, inappropriately low PTH and relative hypercalciuria. Four activating CaSR mutations cause additional renal wasting of
Externí odkaz:
https://doaj.org/article/e1d0764a84934af688578252ec8eb1d4
Autor:
Karin Frank-Raue, Friedhelm Raue
Publikováno v:
Deutsches Ärzteblatt international.
Autor:
Karin Frank-Raue
Publikováno v:
Geburtshilfe und Frauenheilkunde. 81:745-748
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e3582-e3591
Context Long-term data are scarce on large cohorts with sporadic (sMTC) and hereditary medullary thyroid carcinoma (hMTC). Objectives To compare long-term disease-specific survival (DSS) and outcomes between sMTC and hMTC groups. Design Retrospective
Autor:
Karin Frank-Raue, Friedhelm Raue
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 145:1245-1251
Medullary thyroid carcinoma (MTC) is a rare malignancy and compromises only 3 % of all thyroid carcinomas. MTC cells secret calcitonin, which serves as a sensitive tumor marker for screening and follow-up of MTC. Calcitonin screening in patients with
Autor:
Friedhelm Raue, Matthias Kroiss, Theresa Vogel, Julia Wendler, Michael C. Kreissl, Karin Frank-Raue, Christine Spitzweg, Martin Fassnacht
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e2239-e2246
Context The clinical relevance of bone metastases (BM) in advanced medullary thyroid carcinoma (MTC) is poorly described. Objective The objectives of this work are to describe the prevalence of BM, frequency of skeletal related events (SREs), and imp
Autor:
Karin Frank-Raue
Publikováno v:
Der Klinikarzt. 48:541-545
ZUSAMMENFASSUNGIn der Schwangerschaft nimmt die Produktion von Thyroxin um etwa 50 % zu, der Jodbedarf steigt, das Schilddrüsenvolumen nimmt zu. Die Therapie von Schilddrüsenerkrankungen betrifft Mutter und Kind, die Plazentagängigkeit von Jod, Th
Autor:
Karin Frank-Raue, Denise Zwanziger, Lars C. Moeller, Uwe Völker, Anja Viehmann, Helena Kerp, Dagmar Führer, Sebastian Lederbogen, Gudrun Leidig-Bruckner, Dieter Graf, Karin Dunschen, Georg Brabant, Richard Voigtländer, Stefanie Recker, Torquil Watt, Rainer Görges, Johannes W. Dietrich
Publikováno v:
Hormone and Metabolic Research. 51:568-574
The aim of this study was to investigate in a longitudinal approach whether levothyroxine (LT4) substitution has a different impact on quality of life (QoL) and thyroid related QoL in younger (60 years) with elevated thyroid-stimulating hormone (TSH)